Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2024
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and DiagnosisHarrison K Tsai, Mark F Sabbagh, Meagan Montesion, et al.
Blood|March 16, 2025
Lymphoid malignancies in patients with Shwachman-Diamond syndromeHelen D Reed, Hyunwoo Do, Edie Weller, et al.
Histopathology|January 30, 2020
Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasmsJessica L Davis, Sara O Vargas, Erin R Rudzinski, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
British Journal of Haematology|August 14, 2024
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemiaQianqian Zhu, Ram Nambiar, Emily Schultz, et al.
Pediatric Blood & Cancer|March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001Uma H Athale, Yael Flamand, Traci Blonquist, et al.
JAMA Oncology|January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) StudyMarian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
Pageof 7